The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and ...

Clinical trials are facing a crisis amid growing delays, diminishing success rates and rising costs. Companies across the stakeholder spread are investing in AI to ease some of the longstanding ...

The U.S. Capitol in Washington, DC. A bipartisan group of lawmakers has reintroduced legislation to allow immediate expensing of research and development costs, all the way back to 2022 when the tax ...

Please provide your email address to receive an email when new articles are posted on . The FDA issued draft guidance that would streamline testing of biosimilars. A separate plan would eliminate ...